108 related articles for article (PubMed ID: 6969756)
1. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry.
Lanier LL; Warner NL
J Immunol; 1981 Feb; 126(2):626-31. PubMed ID: 6969756
[TBL] [Abstract][Full Text] [Related]
2. Antigen-dependent selection of B lymphoma cells varying in Ia density by cloned antigen-specific L3T4a+ T cells: a possible in vitro model for B cell adaptive differentiation.
Tite JP; Janeway CA
J Mol Cell Immunol; 1984; 1(4):253-65. PubMed ID: 6336593
[TBL] [Abstract][Full Text] [Related]
3. Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle.
Monroe JG; Cambier JC
J Immunol; 1983 Feb; 130(2):626-31. PubMed ID: 6600247
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.
Koch N; Harris AW
J Immunol; 1984 Jan; 132(1):12-5. PubMed ID: 6418793
[TBL] [Abstract][Full Text] [Related]
5. Non-activated guinea-pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies.
Burger R; Scher I; Sharrow SO; Shevach EM
Immunology; 1984 Jan; 51(1):93-102. PubMed ID: 6197362
[TBL] [Abstract][Full Text] [Related]
6. Antigens displayed on murine B lymphocyte precursors.
Kincade PW; Lee G; Watanabe T; Sun L; Scheid MP
J Immunol; 1981 Dec; 127(6):2262-8. PubMed ID: 6975314
[TBL] [Abstract][Full Text] [Related]
7. The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells.
Accolla RS; Carra G; Buchegger F; Carrel S; Mach JP
J Immunol; 1985 May; 134(5):3265-71. PubMed ID: 3872331
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.
Bahler DW; Lord EM; Kennel SJ; Horan PK
Cancer Res; 1984 Aug; 44(8):3317-23. PubMed ID: 6378365
[TBL] [Abstract][Full Text] [Related]
9. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
Sieverts H; Alabaster O; Goldschmidts W; Magrath I
Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
[TBL] [Abstract][Full Text] [Related]
10. Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.
Honsik CJ; Diamant M; Olsson L
Cancer Res; 1986 Feb; 46(2):940-9. PubMed ID: 3484432
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic expression of I-A and I-E/C subregion determinants on murine thymocytes.
Sharrow SO; Ozato K; Sachs DH
J Immunol; 1980 Nov; 125(5):2263-8. PubMed ID: 6159403
[TBL] [Abstract][Full Text] [Related]
13. Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPS.
Harris MR; Kindle CS; Abruzzini AF; Pierce CW; Cullen SE
J Immunol; 1984 Sep; 133(3):1202-8. PubMed ID: 6611366
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies.
Lanier LL; Warner NL; Ledbetter JA; Herzenberg LA
J Immunol; 1981 Oct; 127(4):1691-7. PubMed ID: 7024413
[TBL] [Abstract][Full Text] [Related]
15. Repeated isolation of unique Qa2+ Ia+ clonally derived cell lines from Qa2- mice.
Rosenson RS; Flaherty L; Levine H; Reinisch CL
J Immunol; 1982 Jul; 129(1):382-7. PubMed ID: 6979571
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
17. The structure-function relationship of I-A molecules: correlation of serologic and functional phenotypes of four I-Ak mutant cell lines.
Beck BN; Glimcher LH; Nilson AE; Pierres M; McKean DJ
J Immunol; 1984 Dec; 133(6):3176-82. PubMed ID: 6333456
[TBL] [Abstract][Full Text] [Related]
18. Cytofluorometric isolation of I937, an Ia antigen-bearing variant of the Ia-negative human monocytic cell line U937.
Gitter BD; Finn OJ; Metzgar RS
J Immunol; 1985 Jan; 134(1):280-3. PubMed ID: 3880570
[TBL] [Abstract][Full Text] [Related]
19. Molecular events in B lymphocyte activation: consequences of signals transduced through MHC class II molecules.
Baluyut AR; Pollok KE; Bondada S
Cell Immunol; 1993 Apr; 147(2):353-66. PubMed ID: 8453677
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic drift and clonal variation in differentiation antigen expression on AKR T-cell lymphoma lines grown in vitro.
Howell AL; Richie ER
Nat Immun Cell Growth Regul; 1983-1984; 3(3):143-54. PubMed ID: 6150437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
